Revere Bank - ESG Rating & Company Profile powered by AI
Complete Sustainability assessment of Revere Bank are reached by signing in. This Disclosure score covers seventeen UN Sustainable Development Goals including: 'Zero Hunger', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'. The report of Revere Bank uses data points from across the web and also from available disclosures by Revere Bank.
Revere Bank in the Banks industry gained a UN SDG ESG Transparency Score of 0.5; made up of an environmental score of 0.0, social score of 0.0 and governance score of 1.6.
0.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Landesbank Baden Wuerttemberg | 9.5 | High |
2 | UniCredit Bank AG | 9.0 | High |
... | ... | ... | |
1752 | Shahjalal Islami Bank Ltd | 0.7 | Low |
1752 | Taipei Star Bank | 0.7 | Low |
1768 | Revere Bank | 0.5 | Low |
1768 | CW Bancorp | 0.5 | Low |
1768 | California Bancshares Inc | 0.5 | Low |
1885 | sakartvelos bank'i ss | 0.0 | Low |
1885 | AlphaCredit Capital, S.A. de C.V. | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Revere Bank have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Revere Bank disclose current and historical energy intensity?
Sign up for free to unlockDoes Revere Bank report the average age of the workforce?
Sign up for free to unlockDoes Revere Bank reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Revere Bank disclose its ethnicity pay gap?
Sign up for free to unlockDoes Revere Bank disclose cybersecurity risks?
Sign up for free to unlockDoes Revere Bank offer flexible work?
Sign up for free to unlockDoes Revere Bank have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Revere Bank disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Revere Bank conduct supply chain audits?
Sign up for free to unlockDoes Revere Bank disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Revere Bank conduct 360 degree staff reviews?
Sign up for free to unlockDoes Revere Bank disclose the individual responsible for D&I?
Sign up for free to unlockDoes Revere Bank disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Revere Bank disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Revere Bank disclose water use targets?
Sign up for free to unlockDoes Revere Bank have careers partnerships with academic institutions?
Sign up for free to unlockDid Revere Bank have a product recall in the last two years?
Sign up for free to unlockDoes Revere Bank disclose incidents of discrimination?
Sign up for free to unlockDoes Revere Bank allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Revere Bank issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Revere Bank disclose parental leave metrics?
Sign up for free to unlockDoes Revere Bank disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Revere Bank disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Revere Bank disclose the pay ratio of women to men?
Sign up for free to unlockDoes Revere Bank support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Revere Bank disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Revere Bank reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Revere Bank involved in embryonic stem cell research?
Sign up for free to unlockDoes Revere Bank disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Revere Bank disclose its waste policy?
Sign up for free to unlockDoes Revere Bank report according to TCFD requirements?
Sign up for free to unlockDoes Revere Bank disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Revere Bank disclose energy use targets?
Sign up for free to unlockDoes Revere Bank disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Revere Bank have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Revere Bank
These potential risks are based on the size, segment and geographies of the company.
Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal congestion. It also develops REVTx-200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for immunity; and REVDx-501, a rapid home use diagnostic to detect respiratory viral infection. The company was founded in 2019 and is based in New York, New York.